Published in Clin Exp Immunol on February 01, 1977
Induction of immunoglobulin and antibody synthesis in vitro by lipopolysaccharides. Eur J Immunol (1972) 4.64
Immunologic tissue injury mediated by neutrophilic leukocytes. Adv Immunol (1968) 3.82
The modulation of lymphocyte functions by molecules secreted by macrophages. I. Description and partial biochemical analysis. J Exp Med (1975) 2.54
Separation and characterization of human neutrophil granules. Am J Pathol (1974) 2.50
The pathogenesis of chronic inflammation in experimental antigen-induced arthritis. I. The role of antigen on the local immune response. Arthritis Rheum (1972) 2.16
Generation of C5-derived lysosomal enzyme-releasing activity (C5a) by lysates of leukocyte lysosomes. J Immunol (1974) 2.02
Complement-dependent B-cell activation by cobra venom factor and other mitogens? J Exp Med (1974) 1.97
Effect of leukocyte and synovial membrane extracts on cartilage mucoprotein. J Clin Invest (1960) 1.87
Lysosomal mechanisms of tissue injury in arthritis. N Engl J Med (1972) 1.81
Stimulation of mouse B lymphocytes by trypsin. J Immunol (1974) 1.59
Proteases as mitogens. The Effect of trypsin and pronase on mouse and human lymphocytes. Exp Cell Res (1974) 1.56
Enhancement of the humoral response of T cell-depleted murine spleens by a factor derived from human monocytes in vitro. J Immunol (1974) 1.49
Degradation of immunoglobulins by intracellular proteases in the range of neutral pH. J Immunol (1970) 1.26
Lysosomes in rat thoracic duct lymphocytes. J Exp Med (1972) 1.10
Mitogenic action of trypsin and chymotrypsin. Lancet (1966) 0.98
At least three human neutrophil lysosomal proteases are capable of degrading joint connective tissues. Ann N Y Acad Sci (1975) 0.97
Purification of granulocyte neutral protease from human blood and rheumatoid synovial fluid. Biochim Biophys Acta (1975) 0.85
Lymphocyte transformation induced by human granulocytes. Transplantation (1975) 0.83
Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell (1989) 5.72
Abdominal fat: standardized technique for measurement at CT. Radiology (1999) 4.25
In vitro synthesis of immunoglobulin by rheumatoid synovial membrane. J Clin Invest (1968) 4.01
Molecular structure of human lymphocyte receptor for immunoglobulin E. Cell (1986) 3.34
Lymphokine stimulation of collagen accumulation. J Clin Invest (1976) 2.94
The effect of gold salt on lysosomal enzymes of the peritoneal macrophage. Arthritis Rheum (1966) 2.83
The pathogenesis of chronic inflammation in experimental antigen-induced arthritis. II. Preferential localization of antigen-antibody complexes to collagenous tissues. J Exp Med (1972) 2.74
Interleukin 1 increases the binding of human B and T lymphocytes to endothelial cell monolayers. J Immunol (1986) 2.67
Rheumatoid factor secretion from human Leu-1+ B cells. Science (1987) 2.65
A novel mode of DNA recognition by a beta-sheet revealed by the solution structure of the GCC-box binding domain in complex with DNA. EMBO J (1998) 2.48
IgM rheumatoid factor and low molecular weight IgM. An association with vasculitis. Arthritis Rheum (1974) 2.45
T lymphocyte adhesion to endothelial cells: mechanisms demonstrated by anti-LFA-1 monoclonal antibodies. J Immunol (1986) 2.28
Production of interleukin 1 by human endothelial cells. J Immunol (1986) 2.27
Suppression of adjuvant disease in the rat by heterologous antilymphocyte globulin. J Exp Med (1968) 2.27
Superoxide anion release by human endothelial cells: synergism between a phorbol ester and a calcium ionophore. J Cell Physiol (1986) 2.26
Fc epsilon receptor, a specific differentiation marker transiently expressed on mature B cells before isotype switching. J Exp Med (1986) 2.25
Suppression of experimentally induced polyarthritis in the rat by heterologous anti-lymphocyte serum. Lancet (1966) 2.19
Electron microscopic studies of the cartilage-pannus junction in rheumatoid arthritis. Arthritis Rheum (1976) 2.18
Immunoglobulin synthesis by peripheral blood cells in systemic lupus erythematosus. Arthritis Rheum (1975) 2.09
Antibodies against cell membrane constituents in systemic lupus erythematosus and related diseases. I. Cytotoxic effect of serum from patients with systemic lupus erythematosus (SLE) for allogeneic and for autologous lymphocytes. Clin Exp Immunol (1971) 2.06
Immunofluorescent demonstration of an IgG-B1C complex in synovial lining cells of rheumatoid synovial membrane. Clin Exp Immunol (1969) 2.00
Identification of immunoglobulins and complement in rheumatoid articular collagenous tissues. Arthritis Rheum (1976) 1.94
Inhibition of antigen- and mitogen-induced human lymphocyte proliferation by gold compounds. J Clin Invest (1977) 1.89
Lymphokines in the rheumatoid joint. Arthritis Rheum (1975) 1.87
Isolation of high-affinity memory B cells: phycoerythrin as a probe for antigen-binding cells. Proc Natl Acad Sci U S A (1987) 1.82
A B cell-specific differentiation antigen, CD23, is a receptor for IgE (Fc epsilon R) on lymphocytes. J Immunol (1987) 1.79
Electron microscopic observations of immunoreactive cells in the rheumatoid synovial membrane. Arthritis Rheum (1976) 1.75
Cytomegalovirus (CMV) antigenaemia for rapid diagnosis and monitoring of CMV-associated disease after bone marrow transplantation. Br J Haematol (1994) 1.75
Stimulation of endothelial cell binding of lymphocytes by tumor necrosis factor. J Immunol (1987) 1.73
Human gamma interferon increases the binding of T lymphocytes to endothelial cells. Clin Exp Immunol (1985) 1.67
Negative result: treatment of patients with rheumatoid arthritis with gamma globulin: a double-blind controlled study. Arthritis Rheum (1969) 1.63
Acute myelitis associated with hyperIgEemia and atopic dermatitis. J Neurol Sci (1997) 1.62
Hospital outbreak of MEN-1-derived extended spectrum beta-lactamase-producing Klebsiella pneumoniae. J Infect Chemother (2001) 1.59
A potent and specific agonist, Suc-[Glu9,Ala11,15]-endothelin-1(8-21), IRL 1620, for the ETB receptor. Biochem Biophys Res Commun (1992) 1.57
Immunoelectron microscopic study of the distribution of T cell subsets in rheumatoid synovium. J Exp Med (1983) 1.57
Increased serum angiogenin concentration in colorectal cancer is correlated with cancer progression. Clin Cancer Res (1999) 1.56
Lymphocyte chemotactic activity of human interleukin 1. J Immunol (1984) 1.56
Increased incidence of cytomegalovirus (CMV) infection and CMV-associated disease after allogeneic bone marrow transplantation from unrelated donors. The Fukuoka Bone Marrow Transplantation Group. Bone Marrow Transplant (1997) 1.53
Immunoglobulin and specific antibody synthesis in a chronic inflammatory focus: antigen-induced synovitis. J Immunol (1969) 1.52
Studies of isolated synovial living cells of rheumatoid and nonrheumatoid synovial membranes. Arthritis Rheum (1971) 1.49
Increased superoxide anion release from human endothelial cells in response to cytokines. J Immunol (1986) 1.46
Structure-function analysis of human IL-6 receptor: dissociation of amino acid residues required for IL-6-binding and for IL-6 signal transduction through gp130. EMBO J (1993) 1.46
Evidence of microvascular injury in scleroderma and systemic lupus erythematosus: quantitative study of the microvascular bed. J Lab Clin Med (1968) 1.45
Primary in vitro cell-mediated lympholysis reaction of NZB mice against unmodified targets syngeneic at the major histocompatibility complex. J Exp Med (1978) 1.45
Regional polysterism in the GTP-bound form of the human c-Ha-Ras protein. Biochemistry (1997) 1.44
Decreased 19S antibody response to bacterial antigens in systemic lupus erythematosus. J Clin Invest (1969) 1.43
Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann Neurol (1996) 1.42
Control of human B lymphocyte responsiveness: enhanced suppressor T cell activity after in vitro incubation. J Immunol (1978) 1.41
Minimum 10-year outcome of decompressive laminectomy for degenerative lumbar spinal stenosis. Spine (Phila Pa 1976) (2000) 1.41
Electron microscopic studies of lymphoid cells in the rheumatoid synovial membrane. Arthritis Rheum (1973) 1.41
Prevention of glomerulonephritis and prolonged survival in New Zealand Black/New Zealand White F1 hybrid mice fed an essential fatty acid-deficient diet. J Clin Invest (1981) 1.41
Effects of bacterial lipopolysaccharide on the binding of lymphocytes to endothelial cell monolayers. J Immunol (1986) 1.41
Postcontrast magnetic resonance imaging to predict progression of traumatic epidural and subdural hematomas in the acute stage. Neurosurgery (1998) 1.40
IgG and IgM rheumatoid factors in rheumatoid arthritis. Quantitative response to penicillamine therapy and relationship to disease activity. Arthritis Rheum (1983) 1.39
Effect of a gold salt on the immune response. Arthritis Rheum (1967) 1.38
Viruses and the connective tissue diseases. Ann Intern Med (1971) 1.37
Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine. J Clin Invest (1989) 1.36
Relation of cellular infiltration of rheumatoid synovial membrane to its immune response. Arthritis Rheum (1974) 1.34
The in vitro and in vivo induction of anti-double-stranded DNA antibodies in normal and autoimmune mice. J Immunol (1982) 1.31
Coinfection of hepatitis C virus in patients with chronic hepatitis B infection. J Hepatol (1994) 1.31
Virus antibody levels in systemic lupus erythematosus. Arthritis Rheum (1972) 1.31
Cold-insoluble complexes and complement levels in systemic lupus erythematosus. N Engl J Med (1969) 1.31
Natural antibodies to procaine amide. Clin Exp Immunol (1968) 1.31
Interleukin-1 lymphocyte chemotactic activity in rheumatoid arthritis synovial fluid. Arthritis Rheum (1986) 1.30
Characterization of a B cell defect in the NZB mouse manifested by an increased ratio of surface IgM to IgD. J Immunol (1978) 1.29
Electron microscopic study of rheumatoid synovial vasculature. Intimate relationship between tall endothelium and lymphoid aggregation. J Clin Invest (1986) 1.29
Differential effects of 6-mercaptopurine and cyclophosphamide on autoimmune phenomena in NZB mice. Clin Exp Immunol (1971) 1.28
Apoptosis signal-regulating kinase 1 (ASK1) is an intracellular inducer of keratinocyte differentiation. J Biol Chem (2001) 1.27
Hydroxyl radical scavenging by rebamipide and related compounds: electron paramagnetic resonance study. Free Radic Biol Med (1995) 1.27
Serum IgG and IgM rheumatoid factors by solid phase radioimmunoassay. A comparison between adult and juvenile rheumatoid arthritis. Arthritis Rheum (1981) 1.26
Immunoglobulin classes of DNA binding activity in serum and skin in systemic lupus erythematosus. J Clin Invest (1977) 1.26
Degradation of immunoglobulins by intracellular proteases in the range of neutral pH. J Immunol (1970) 1.26
Epiregulin, a novel member of the epidermal growth factor family, is an autocrine growth factor in normal human keratinocytes. J Biol Chem (2000) 1.26
Lymphotoxin formation by lymphocytes and muscle in polymyositis. J Clin Invest (1972) 1.26
The biologically active constituents of Ganoderma lucidum (Fr.) Karst. Histamine release-inhibitory triterpenes. Chem Pharm Bull (Tokyo) (1985) 1.26
Phagocytosis of immune complexes by polymorphonuclear leucocytes in patients with Felty's syndrome. Clin Exp Immunol (1977) 1.25
Nephrosis in the rat induced by rat kidney extracts. Ann N Y Acad Sci (1965) 1.24
Altered cation coupling to melibiose transport in mutants of Escherichia coli. J Biol Chem (1982) 1.24
Endothelial cell activation induced by tumor necrosis factor and lymphotoxin. Am J Pathol (1989) 1.23
Inhibitor of macrophage migration produced by polymorphonuclear leucocytes. J Reticuloendothel Soc (1970) 1.23
Primary human immunodeficiency virus type 1 viremia and central nervous system invasion in a novel hu-PBL-immunodeficient mouse strain. J Virol (1997) 1.23
Production of a macrophage migration inhibitory factor in rabbits with experimental arthritis. Clin Exp Immunol (1973) 1.23
Inhibition of human endothelial cell proliferation by gold compounds. J Clin Invest (1987) 1.22
Circulating deoxyribonucleic acid--synthesizing mononuclear leukocytes. I. Increased numbers of proliferating mononuclear leukocytes in inflammatory disease. J Lab Clin Med (1970) 1.20
Response of the rheumatoid synovial membrane to exogenous immunization. J Clin Invest (1971) 1.20
Surgical indication and significance of portal vein resection in biliary and pancreatic cancer. Surgery (1991) 1.18
Diet in the treatment of rheumatoid arthritis. Arthritis Rheum (1983) 1.17
Electron-dense deposits following injection of gold sodium thiomalate and thiomalic acid. Arthritis Rheum (1968) 1.16
IgG and IgM rheumatoid factor synthesis in rheumatoid synovial membrane cell cultures. Arthritis Rheum (1985) 1.15
Phorbol ester-stimulated T lymphocytes show enhanced adhesion to human endothelial cell monolayers. J Immunol (1986) 1.14
Abnormal polyclonal B cell activation in NZB/NZW F1 mice. J Immunol (1977) 1.14
The effect of D-penicillamine on mitogen-induced human lymphocyte proliferation: synergistic inhibition by D-penicillamine and copper salts. J Immunol (1978) 1.14
Pathways to chronic inflammation in rheumatoid synovitis. Fed Proc (1987) 1.14
Inhibition of human helper T cell function in vitro by D-penicillamine and CuSO4. J Clin Invest (1980) 1.13
Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty. Circulation (1999) 1.12
Immune interferon enhances the production of interleukin 1 by human endothelial cells stimulated with lipopolysaccharide. J Immunol (1986) 1.12
The transport mechanisms of (222)Rn in soil at Tateishi as an anomaly spot in Japan. Appl Radiat Isot (2005) 1.12
Plasma concentrations of brain natriuretic peptide in patients with subarachnoid hemorrhage. Stroke (1998) 1.12
Rebamipide, novel prostaglandin-inducer accelerates healing and reduces relapse of acetic acid-induced rat gastric ulcer. Comparison with cimetidine. Dig Dis Sci (1995) 1.12